137 related articles for article (PubMed ID: 6211187)
1. Mononuclear-cell infiltration in ovarian cancer. III. Suppressor-cell and ADCC activity of macrophages from ascitic and solid ovarian tumours.
Haskill S; Koren H; Becker S; Fowler W; Walton L
Br J Cancer; 1982 May; 45(5):747-53. PubMed ID: 6211187
[TBL] [Abstract][Full Text] [Related]
2. Mononuclear-cell infiltration in ovarian cancer. II. Immune function of tumour and ascites-derived inflammatory cells.
Haskill S; Koren H; Becker S; Fowler W; Walton L
Br J Cancer; 1982 May; 45(5):737-46. PubMed ID: 6177328
[TBL] [Abstract][Full Text] [Related]
3. Mononuclear-cell infiltration in ovarian cancer. I. Inflammatory-cell infiltrates from tumour and ascites material.
Haskill S; Becker S; Fowler W; Walton L
Br J Cancer; 1982 May; 45(5):728-36. PubMed ID: 6979349
[TBL] [Abstract][Full Text] [Related]
4. Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas: augmentation by interferon, lymphokines and endotoxin.
Peri G; Polentarutti N; Sessa C; Mangioni C; Mantovani A
Int J Cancer; 1981 Aug; 28(2):143-52. PubMed ID: 6172388
[TBL] [Abstract][Full Text] [Related]
5. Antibody-dependent and -independent cytotoxicity of human mononuclear phagocytes: defective stimulation of tumoricidal activity in milk macrophages.
Biondi A; Peri G; Colombo N; Bolis G; Mantovani A
Clin Exp Immunol; 1982 Sep; 49(3):701-8. PubMed ID: 7172502
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity on tumor cells of peripheral blood monocytes and tumor-associated macrophages in patients with ascites ovarian tumors.
Mantovani A; Polentarutti N; Peri G; Shavit ZB; Vecchi A; Bolis G; Mangioni C
J Natl Cancer Inst; 1980 Jun; 64(6):1307-15. PubMed ID: 6246299
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
[TBL] [Abstract][Full Text] [Related]
8. Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients.
Gordon IO; Freedman RS
Clin Cancer Res; 2006 Mar; 12(5):1515-24. PubMed ID: 16533776
[TBL] [Abstract][Full Text] [Related]
9. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
[TBL] [Abstract][Full Text] [Related]
10. Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice.
Voutsas IF; Pistamaltzian N; Tsiatas ML; Skopeliti M; Katsila T; Mavrothalassiti I; Spyrou S; Dimopoulos MA; Tsitsilonis OE; Bamias A
Eur J Cancer; 2013 May; 49(7):1706-14. PubMed ID: 23276721
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of natural killer activity by human bronchoalveolar macrophages.
Bordignon C; Villa F; Allavena P; Introna M; Biondi A; Avallone R; Mantovani A
J Immunol; 1982 Aug; 129(2):587-91. PubMed ID: 6177770
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas.
Allavena P; Introna M; Mangioni C; Mantovani A
J Natl Cancer Inst; 1981 Aug; 67(2):319-25. PubMed ID: 6943371
[TBL] [Abstract][Full Text] [Related]
13. Effects on in vitro tumor growth of macrophages isolated from human ascitic ovarian tumors.
Mantovani A; Peri G; Polentarutti N; Bolis G; Mangioni C; Spreafico F
Int J Cancer; 1979 Feb; 23(2):157-64. PubMed ID: 761940
[TBL] [Abstract][Full Text] [Related]
14. Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma.
Sica A; Saccani A; Bottazzi B; Bernasconi S; Allavena P; Gaetano B; Fei F; LaRosa G; Scotton C; Balkwill F; Mantovani A
J Immunol; 2000 Jan; 164(2):733-8. PubMed ID: 10623817
[TBL] [Abstract][Full Text] [Related]
15. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
16. Tumour-induced suppressor macrophages in rats: differences in their suppressive effects on the Con A and PHA responses.
Mizushima Y; Wepsic HT; Yamamura Y; Desilva MA
Clin Exp Immunol; 1984 Aug; 57(2):371-9. PubMed ID: 6235988
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lymphocyte mitogenesis by factor(s) released from macrophages isolated from ascitic fluid of advanced ovarian cancer patients.
Sheid B; Boyce J
Cancer Immunol Immunother; 1984; 17(3):190-4. PubMed ID: 6332671
[TBL] [Abstract][Full Text] [Related]
18. Cytolytic activity of T lymphocytes isolated from ovarian carcinoma ascitic fluid. Analysis at the population and clonal level.
Biassoni R; Prigione I; Di Marco E; Ferrini S
Ric Clin Lab; 1985; 15(2):177-83. PubMed ID: 3877335
[TBL] [Abstract][Full Text] [Related]
19. Clonal analysis of T lymphocytes isolated from ovarian carcinoma ascitic fluid. Phenotypic and functional characterization of T-cell clones capable of lysing autologous carcinoma cells.
Ferrini S; Biassoni R; Moretta A; Bruzzone M; Nicolin A; Moretta L
Int J Cancer; 1985 Sep; 36(3):337-43. PubMed ID: 3875569
[TBL] [Abstract][Full Text] [Related]
20. Lectin-induced suppression of antibody-dependent cellular cytotoxicity (ADCC) of human peripheral blood mononuclear cells.
Gergely P; Láng I; Kalmár L; González-Cabello R
Acta Med Acad Sci Hung; 1980; 37(4):389-94. PubMed ID: 7234306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
